Bob Miller, CTN
Friday

Bob Miller, CTN

Epigenetic Factors Combined with Genetic Variants that Accelerate mTOR and Inhibit Autophagy in Chronic Illness

Bob Miller, CTN, is a Certified Traditional Naturopath specializing in the field of genetic-specific nutrition.  He earned his naturopathic degree from Trinity School of Natural Health and is board certified. In 1993, Bob Miller opened the Tree of Life Health practice and he has served as a traditional naturopath for 20+ years. For the past several years, he has been engaged with genetic variants and related research. Working with many clients, he is astounded at how many peoples’ health concerns are related to the genetic issues.

A Formulator – recognizing that there was not a nutritional supplement line on the market comprehensive enough to address all of the possible genetic variants, he began working with a national company, Professional Health Products, to formulate an Epigenetics line of products for use by health care providers. Currently he has formulated 55 nutritional products with more under development. His formulas are being recognized for their unique approach to supporting enzyme function and supporting the removal of environmental and naturally occurring toxins.

An Educator – Bob lectures at nationwide seminars to educate physicians and health care practitioners about genetic variants and nutritional supplementation for achieving optimal health, and holds live webinars other Thursday evening for health professionals.

Genetic Analysis Software – For the past several years, Bob has been creating a propriety software program, MethylGenetic Nutritional Analysis™, which compares genetic variants, labs and symptoms, to allow health professionals to create custom made nutritional protocols for their patients. The software has been received with great acclaim in the industry and has a growing following.

A Researcher – To support his growing genetic research efforts, Bob founded the NutriGenetic Research Institute in 2015 to research and publish reports on the relationship between genetic variants and labs and presenting symptoms.

His first research project on genetic variants in those with chronic Lyme Disease, was one of two winners for research by the ILADS international meeting held in Helsinki, Finland. His Phase II, Phase III and Phase IV studies of Lyme disease have also been presented at the American ILADS conferences internationally and locally.

Learn more: http://TOLHealth.com, http://DNASupplementation.com